Letter to the editor about: “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
Saved in:
| Main Authors: | Simon Ville, Leo Drapeau, Jean Paraire, Mehdi Maanaoui, Marie Frimat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924016127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01) -
Response to Letter to the Editor From Ville S. et al. About: “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-06-01) -
Transplant-associated Thrombotic Microangiopathy: An Enigma Treated with Eculizumab
by: S. Ravitej, et al.
Published: (2024-10-01) -
A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy
by: Caroline Duineveld, et al.
Published: (2024-05-01) -
Rare Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Posttransplant Thrombotic Microangiopathy
by: Akila Viswanathan, et al.
Published: (2024-12-01)